Loading clinical trials...
Loading clinical trials...
This clinical study aims to evaluate the use of i3.1 probiotic in participants who meet the Institute of Medicine (Canadian Consensus Criteria) case definition for ME/CFS and who may or may not be dia...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Nova Southeastern University
NCT07089420 · IBD (Inflammatory Bowel Disease), IBS - Irritable Bowel Syndrome, and more
NCT04806620 · Post-Acute COVID-19 Syndrome, ME/CFS, and more
NCT07352254 · ME/CFS
NCT06952413 · Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
NCT05778006 · ME/CFS, CFS/ME, and more
Institute for Neuroimmune Medicine
Fort Lauderdale, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions